Friendly bacteria vs. cancer drug side effects

NCT ID NCT06892093

Summary

This study is testing whether probiotic supplements can help prevent severe diarrhea in people with HER2-positive breast cancer who are taking the drug neratinib. About 308 participants will be randomly assigned to take either probiotics or a placebo, while all will also receive standard anti-diarrhea medication. The main goal is to see if the probiotics reduce how often and how bad the diarrhea gets, and researchers will also check if the probiotics change gut bacteria.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.